NDC 57894-651 – Tremfya
Guselkumab 200 mg/2mL · Injection · Subcutaneous
Product NDC57894-651
Product details
- Brand name
- Tremfya
- Generic name
- Guselkumab
- Labeler
- Janssen Biotech, Inc.
- Dosage form
- Injection
- Route
- Subcutaneous
- Marketing category
- BLA · BLA761061
- Marketed since
- September 11, 2024
- Listing expires
- December 31, 2027
- Pharmacologic class
- Interleukin-23 Antagonist
Active ingredients
- Guselkumab 200 mg/2mL
Package NDC codes (4)
| Package NDC | Description | Since |
|---|---|---|
| 57894-651-02 | 1 SYRINGE in 1 CARTON (57894-651-02) / 2 mL in 1 SYRINGE (57894-651-01) | Sep 11, 2024 |
| 57894-651-04 | 2 CARTON in 1 CARTON (57894-651-04) / 1 SYRINGE in 1 CARTON (57894-651-02) / 2 mL in 1 SYRINGE (57894-651-01) | Mar 20, 2025 |
| 57894-651-22 | 1 SYRINGE in 1 CARTON (57894-651-22) / 2 mL in 1 SYRINGE (57894-651-11) | Sep 11, 2024 |
| 57894-651-92 | 1 SYRINGE in 1 CARTON (57894-651-92) / 2 mL in 1 SYRINGE (57894-651-99) | Sep 11, 2024 |
Recalls mentioning this NDC
- D-0314-2021 Apr 7, 2021 · Class III
Temperature Abuse